MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Vitae Pharmaceuticals Company Profile (NASDAQ:VTAE)

Consensus Ratings for Vitae Pharmaceuticals (NASDAQ:VTAE) (?)
Ratings Breakdown: 6 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $19.00 (97.51% upside)

Analysts' Ratings History for Vitae Pharmaceuticals (NASDAQ:VTAE)
Show:
DateFirmActionRatingPrice TargetActions
5/25/2016WedbushReiterated RatingOutperform$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/11/2016BMO Capital MarketsInitiated CoverageOutperform$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/20/2016Piper JaffrayReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2016JMP SecuritiesUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2016Stifel NicolausUpgradeHold -> Buy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2015Wells FargoInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/28/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha